secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2025-09-29T23:59:59+00:00
Accession:  0001493152-25-015846
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics appoints Kevin Chen as independent director effective Sept 26, 2025
--------------------------------------------------------------------------------

- Kevin Chen, 47, appointed as independent director, effective immediately.
- Chen serves as Chief Economist and CIO of Horizon Financial.
- He holds board seats at CurrenC Group, Australian Oilseeds Investments, Scage Future, Capitan Investment.
- Former board member of Infint Acquisition Corporation; adjunct professor at NYU.
- Chen holds PhD in Finance from University of Lausanne, and BA from Renmin University.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315225015846/0001493152-25-015846-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315225015846/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-015846

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer